• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在澳大利亚 COVID-19 大流行期间,从事阿片类激动剂治疗的人作为一个反公共领域:一项定性研究。

People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study.

机构信息

The Kirby Institute, UNSW Sydney, Sydney, Australia.

Centre for Social Research in Health, UNSW Sydney, Sydney, Australia.

出版信息

Drug Alcohol Rev. 2023 Jan;42(1):203-212. doi: 10.1111/dar.13531. Epub 2022 Aug 31.

DOI:10.1111/dar.13531
PMID:36054577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9538012/
Abstract

INTRODUCTION

People receiving opioid agonist treatment (OAT) are at higher risk of comorbidities, poverty and discrimination, which Big Events like the COVID-19 pandemic may exacerbate. The behaviours of people receiving OAT do not always align with normative behaviours as conceived by ruling institutions and laws, and so the group becomes a counterpublic, not imagined in mainstream public discourse. The aim of this study was to understand how people receiving OAT, as a counterpublic, implemented practises of care to mitigate negative health outcomes during COVID-19.

METHODS

Participants were recruited via eight peer-led organisations across Australia. In-depth, semi-structured interviews were completed between August and December 2020 with 40 people receiving OAT. The analysis centres practises of care, allowing interactions that influence the health of participants, to be understood in their unique contexts.

RESULTS

Aspects of the COVID-19 state response were designed for an idealised public, demonstrated by the increased policing that accompanied enforcement of restrictions which was detrimental to the wellbeing of people receiving OAT. Counterpublic health strategies employed by people receiving OAT were disrupted, but participants were often able to adapt to the changing context.

DISCUSSION AND CONCLUSION

This study elucidates how practises of care among people receiving OAT are enacted and disrupted during a Big Event, with implications beyond the COVID-19 pandemic for future Big Events. The study findings evidence the need for policies that mitigate the impact of Big Events such as supporting re-groupment within the counterpublic, legitimising counterpublic health strategies and stopping the criminalisation of people who use drugs.

摘要

简介

接受阿片类激动剂治疗(OAT)的人患合并症、贫困和歧视的风险更高,而像 COVID-19 大流行这样的重大事件可能会使这些问题恶化。接受 OAT 治疗的人的行为并不总是与统治机构和法律所设想的规范行为一致,因此该群体成为一个反公众,而不是主流公共话语中想象的那样。本研究旨在了解接受 OAT 治疗的人作为一个反公众,如何实施护理实践,以减轻 COVID-19 期间的负面健康结果。

方法

参与者通过澳大利亚各地的八个同伴领导组织招募。2020 年 8 月至 12 月期间,对 40 名接受 OAT 治疗的人进行了深入的半结构化访谈。该分析以护理实践为中心,允许在其独特的背景下理解影响参与者健康的互动。

结果

COVID-19 国家应对措施的某些方面是为理想的公众设计的,这表现在加强执法以执行限制措施,这对接受 OAT 治疗的人的福祉造成了不利影响。接受 OAT 治疗的人采用的反公众健康策略受到干扰,但参与者通常能够适应不断变化的环境。

讨论和结论

本研究阐明了 COVID-19 大流行期间,接受 OAT 治疗的人在重大事件中的护理实践是如何实施和中断的,这对未来的重大事件具有超越 COVID-19 大流行的意义。研究结果表明,需要制定政策来减轻重大事件的影响,例如支持反公众内部的重新组合,使反公众健康策略合法化,并停止对吸毒者的定罪。

相似文献

1
People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study.在澳大利亚 COVID-19 大流行期间,从事阿片类激动剂治疗的人作为一个反公共领域:一项定性研究。
Drug Alcohol Rev. 2023 Jan;42(1):203-212. doi: 10.1111/dar.13531. Epub 2022 Aug 31.
2
"You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic.“即使在全球大流行期间,我们也会上门给药”:一项关于 COVID-19 大流行期间适应性阿片类激动剂治疗提供情况的定性研究。
Int J Drug Policy. 2023 Apr;114:103998. doi: 10.1016/j.drugpo.2023.103998. Epub 2023 Mar 6.
3
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.在提供阿片类激动剂治疗以实现接受治疗者获得公平照护方面的去实施化:一项定性研究。
Implement Sci. 2023 Jun 9;18(1):22. doi: 10.1186/s13012-023-01281-4.
4
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.评估在 COVID-19 大流行限制期间,在安大略省多伦多为注射吸毒者提供阿片类激动剂治疗的干预措施。
Int J Drug Policy. 2022 Jun;104:103680. doi: 10.1016/j.drugpo.2022.103680. Epub 2022 Apr 13.
5
Mal/adaptations: A qualitative evidence synthesis of opioid agonist therapy during major disruptions.适应不良:重大干扰期间阿片类激动剂治疗的定性证据综合。
Int J Drug Policy. 2022 Mar;101:103556. doi: 10.1016/j.drugpo.2021.103556. Epub 2021 Dec 11.
6
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.COVID-19大流行期间及之后用于阿片类物质使用障碍的居家注射用阿片类药物亟待解决:一项案例研究
Subst Abuse Treat Prev Policy. 2021 Mar 5;16(1):22. doi: 10.1186/s13011-021-00358-x.
7
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study.俄罗斯入侵对乌克兰阿片类激动剂治疗项目的影响:一项定性研究。
Drug Alcohol Depend. 2024 Feb 1;255:111069. doi: 10.1016/j.drugalcdep.2023.111069. Epub 2023 Dec 26.
8
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis.COVID-19 大流行对加拿大安大略省阿片类激动剂治疗停药率的影响:一项基于人群的时间序列分析。
Drug Alcohol Depend. 2022 Jul 1;236:109459. doi: 10.1016/j.drugalcdep.2022.109459. Epub 2022 Apr 14.
9
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.澳大利亚注射吸毒者阿片类激动剂治疗中断的发生率及相关因素。
Addiction. 2021 Mar;116(3):525-535. doi: 10.1111/add.15168. Epub 2020 Jul 14.
10
Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.患有阿片类药物使用障碍的人在 COVID-19 大流行期间的经历:一项定性研究。
PLoS One. 2021 Jul 29;16(7):e0255396. doi: 10.1371/journal.pone.0255396. eCollection 2021.

引用本文的文献

1
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015-2022.2015 - 2022年马里兰州巴尔的摩市注射吸毒者在新冠疫情期间的药物治疗及支持服务利用情况:一项中断时间序列分析
Int J Drug Policy. 2025 Apr;138:104746. doi: 10.1016/j.drugpo.2025.104746. Epub 2025 Mar 3.
2
Historical and theoretical roots of the big events framework.大事件框架的历史和理论根源。
Int J Drug Policy. 2024 Nov;133:104606. doi: 10.1016/j.drugpo.2024.104606. Epub 2024 Oct 7.
3
Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study.在提供阿片类激动剂治疗以实现接受治疗者获得公平照护方面的去实施化:一项定性研究。
Implement Sci. 2023 Jun 9;18(1):22. doi: 10.1186/s13012-023-01281-4.